Polyketides, a large family of bioactive natural products, are synthesized
from building blocks derived from a-carboxylated Coenzyme A thioesters such
as malonyl-CoA and (2S)-methylmalonyl-CoA. The productivity of polyketide
fermentation processes in natural and heterologous hosts is frequently limi
ted by the availability of these precursors in vivo. We describe a metaboli
c engineering strategy to enhance both the yield and volumetric productivit
y of polyketide biosynthesis. The genes matB and matC from Rhizobium trifol
ii encode a malonyl-CoA synthetase and a putative dicarboxylate transport p
rotein, respectively. These proteins can directly convert exogenous malonat
e and methylmalonate into their corresponding CoA thioesters with an ATP re
quirement of 2 mol per mol of acyl-CoA produced. Heterologous expression of
matBC in a recombinant strain of Streptomyces coelicolor that produces the
macrolactone 6-deoxyerythronolide B results in a 300% enhancement of macro
lactone titers. The unusual efficiency of the bioconversion is illustrated
by the fact that approximately one-third of the methylmalonate units added
to the fermentation medium are converted into macrolactones. The direct con
version of inexpensive feedstocks such as malonate and methylmalonate into
polyketides represents the most carbon- and energy-efficient route to these
high value natural products and has implications for cost-effective fermen
tation of numerous commercial and development-stage small molecules.